Methotrexate and Pulmonary embolism - a phase IV clinical study of FDA data
We study 566,827 people who have side effects when taking Methotrexate. Pulmonary embolism is found, especially among people who are female, 60+ old, have been taking the drug for < 1 month, also take Humira and have Systemic lupus erythematosus.
The phase IV clinical study analyzes which people take Methotrexate and have Pulmonary embolism. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
566,827 people reported to have side effects when taking Methotrexate.
Among them, 4,038 people (0.71%) have Pulmonary embolism.
What is Methotrexate?
Methotrexate has active ingredients of methotrexate sodium. It is used in rheumatoid arthritis. Currently, eHealthMe is studying from 571,366 Methotrexate users.
What is Pulmonary embolism?
Pulmonary embolism (blockage of the main artery of the lung) is found to be associated with 3,357 drugs and 2,860 conditions by eHealthMe. Currently, we are studying 155,619 people who have Pulmonary embolism.
Number of Methotrexate and Pulmonary embolism reports submitted per year:
Time on Methotrexate when people have Pulmonary embolism *:
Gender of people who have Pulmonary embolism when taking Methotrexate*:
Age of people who have Pulmonary embolism when taking Methotrexate *:
Common drugs people take besides Methotrexate *:
Common side effects people have besides Pulmonary embolism *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Methotrexate and have Pulmonary embolism?Check whether Pulmonary embolism is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Henien M, Carey B, Hullah E, Sproat C, Patel V, "methotrexate-associated osteonecrosis of the jaw: A report of two cases", Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2017 Dec .
Methotrexate side effects by duration, gender and age:
- Methotrexate side effects (571,366 reports)
Pulmonary embolism treatments and more:
- Pulmonary embolism (155,619 reports)
Common drugs associated with Pulmonary embolism:
- Yasmin: 11,346 reports
- Yaz: 9,748 reports
- Nuvaring: 6,767 reports
- Prednisone: 6,523 reports
- Xarelto: 5,256 reports
- Vioxx: 4,935 reports
- Aspirin: 4,528 reports
- Methotrexate: 4,038 reports
- Revlimid: 3,600 reports
- Omeprazole: 3,535 reports
All the drugs that are associated with Pulmonary embolism:
- Pulmonary embolism (3,357 drugs)
Common conditions associated with Pulmonary embolism:
- Birth control: 10,673 reports
- Multiple myeloma: 4,989 reports
- Pain: 4,719 reports
- Rheumatoid arthritis: 4,336 reports
- High blood pressure: 4,307 reports
All the conditions that are associated with Pulmonary embolism:
- Pulmonary embolism (2,860 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on methotrexate sodium (the active ingredients of Methotrexate) and Methotrexate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Propranolol Hydrochloride and Neutrophil Percentage Increased - a minute ago
- Minoxidil and Simvastatin drug interaction - a minute ago
- Prednisone and Oxycodone drug interaction - 2 minutes ago
- Arava and Swelling - 2 minutes ago
- Lutein and Stools - Watery - 2 minutes ago
- Lutein and Diarrhea - 2 minutes ago
- Silodosin and Cellulitis - 2 minutes ago
- Amlodipine and Asa drug interaction - 3 minutes ago
- Theo-Dur and Dementia - 3 minutes ago
- Chantix and Breast Pain - 3 minutes ago